Efficacy and safety of Touchi extract, an α-glucosidase inhibitor derived from fermented soybeans, in non-insulin-dependent diabetic mellitus

Journal of Nutritional Biochemistry

Volumn 12, Issue 6, 2001, Pages 351-356

  Hiroyuki, Fujita ^a   Tomohide, Yamagami ^a   Kazunori, Ohshima ^b  

^a Nippon Supplement Inc   (Japan)

^b Ohshima Clinic   (Japan)

Author keywords

glucosidase inhibitor; Anti hyperglycemic effect; Non insulin dependent diabetic mellitus; Touchi extract

Indexed keywords

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INTESTINE ENZYME; LIPID; ORAL ANTIDIABETIC AGENT; TOUCHI EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERMENTATION; FOOD; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; SOYBEAN; TRADITIONAL MEDICINE; VOLUNTEER;

GLYCINE MAX; ILEX COOKII;

EID: 0034967453     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(01)00149-8     Document Type: Article

References (17)

1. α-glucosidase inhibitors in diabetes; efficacy in NIDDM subjects
2. A preliminary review of its pharmacodynamic and pharmacokinetics properties, and therapeutic potential
3. Effect of an α-glucosidase inhibitor (voglibose), in combination with sulphonilureas, on glycaemic control in type 2 diabetes patients
4. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycaemic control over 3 years (U.K. Prospective Diabetes Study 44)
5. LKPNM; a prodrug type ACE-inhibitory derived from fish protein
6. Classification and antihypertensive activity of angiotensin I-converting enzyme derived from food proteins
7. In vitro survey of α-glucosidase inhibitory food components
8. Complete amino acid sequence of an α-amylase inhibitor in wheat kernel (0.19-inhibitor)
9. Isolation and identification of α-glucosidase inhibitors from Tochu-cha (Encommia ulmoides)
10. α-amylase inhibitors from Rosell (Hibiscus sabdariffa Linn.) Tea
11. Inhibition of intestinal α-glucosidases and sugar absorption by flavones
12. The effects of the α-glucosidase inhibitor BAY g5421 (acarbose) on meal stimulated elevations of circulating glucose, insulin and triglyceride levels in man
13. The effects of the α-glucosidase inhibitor BAY g5421 (acarbose) on postprandial glucose, serum insulin and triglyceride levels: dose-time-responserelationship in man
14. Changes in plasma lipoprotein levels during medication with a glucosidase-hydrolase inhibitor (acarbose)
15. Lower triglyceride production during carbohydrate-rich diet through acarbose, a glucosidase hydrolase inhibitor